Showing 34,817 results

Filters

Very poor knowledge of HIV among London hospital staff – HIV update, 25 November 2020

November 2020
Drug policy & policing

Policing Associated With Higher HIV Risks Among People Who Inject Drugs

Editor's pick
Filter
25 November 2020
Drug interactions & pharmacokinetics

Can HIV Meds Interact With COVID-19 Treatment? Here's What We Know

Editor's pick
TheBody
25 November 2020
PrEP programmes & uptake

Glasgow outreach service shows the feasibility of PrEP for people who inject drugs

News
24 November 2020
Treatment outcomes & life expectancy

US: HIV-Related Deaths Decline, but Disparities Still Exist Among Multiple Populations

Editor's pick
American Journal of Managed Care
24 November 2020
Lung disease

Respiratory problems and bronchitis more common in people with HIV

News
24 November 2020
Testing & health monitoring

Study: Delay lab tests in low-risk HIV patients to minimize COVID-19 exposure

Editor's pick
Healio
24 November 2020
Drug policy & policing

Policy Insight: UK government drugs experts recommend reclassifying GHB to a Class B drug

Editor's pick
Volteface
24 November 2020
How HIV works

Viral Reservoir’s Production of HIV RNA Tied to Harmful Inflammation

Editor's pick
POZ
23 November 2020
Coronavirus

Switzerland: HIV infections drop by a third

Editor's pick
Swiss Info
23 November 2020
Ethnic & cultural minorities

UK: Black people less likely to be engaged in HIV care, with more cases of viral rebound

News
23 November 2020
People & personal stories

'We need to be honest': the PHE expert shining light on Covid and inequality

Editor's pick
The Guardian
23 November 2020
Experiences of stigma

Very poor knowledge of HIV among staff at major London hospitals

News
23 November 2020
Mental & emotional health & wellbeing

How middle-aged queer men have prevailed over four decades of HIV/AIDS

Editor's pick
CTV News
20 November 2020
PrEP programmes & uptake

Injectable PrEP tops list as the preferred choice for adolescent girls in Cape Town

Editor's pick
Be In The Know
20 November 2020
Government, leadership & policy

NYC’s Leather Daddy HIV Czar Is Going to the CDC—And Advocates Nationwide Are Thrilled

Editor's pick
TheBody
20 November 2020
Tuberculosis & HIV

TB policies aren't working. Here's why.

Editor's pick
Devex
20 November 2020
New & experimental HIV treatments

Data sets up 2021 filings for Gilead's twice-a-year HIV drug lenacapavir

Editor's pick
Pharmaphorum
20 November 2020
Sexually transmitted infections prevention

DoxyPEP for STIs: Are We Ready for Prophylactic Doxycycline for MSM on HIV PrEP?

Editor's pick
TheBodyPro
20 November 2020
Injectable & long-acting HIV treatment

A Long-Lasting, More Effective HIV Drug Is A Psychological Relief For Patients

Editor's pick
NPR
20 November 2020
New & experimental HIV treatments

Gilead Announces Investigational Long-Acting HIV-1 Capsid Inhibitor, Lenacapavir, Achieves Primary Endpoint in Phase 2/3 Study in Heavily Treatment-Experienced People Living With HIV

Editor's pick
Gilead press release
20 November 2020
HIV treatment for children & young people

WHO and other stakeholders join forces to accelerate access to effective paediatric HIV and tuberculosis diagnostics and medicines

Editor's pick
World Health Organization
20 November 2020
Harm reduction

Harm Reduction “Satellite Sites” Are a Powerful, Underutilized Model

Editor's pick
Filter
20 November 2020
Treatment outcomes & life expectancy

H.I.V. Death Rates Fell by Half 2010-2018, C.D.C. Says

Editor's pick
New York Times
20 November 2020